{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:39:39Z","timestamp":1779302379581,"version":"3.51.4"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1097\/mjt.0b013e3181c9dac6","type":"journal-article","created":{"date-parts":[[2010,3,24]],"date-time":"2010-03-24T08:15:25Z","timestamp":1269418525000},"page":"198-205","source":"Crossref","is-referenced-by-count":109,"title":["Primary Sclerosing Cholangitis Associated with Elevated ImmunoglobulinG4: Clinical Characteristics and Response to Therapy"],"prefix":"10.1097","volume":"18","author":[{"given":"Einar","family":"Bj\u00f6rnsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh","family":"Chari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Gossard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Smyrk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Lindor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20210202","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.21685","article-title":"Immunoglobulin G4 associated cholangitis: Description of an emerging clinical entity based on review of the literature.","volume":"45","author":"Bjornsson","year":"2007","journal-title":"Hepatology"},{"key":"R2-4-20210202","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/MOG.0b013e3282f6a7c5","article-title":"Immunoglobulin G4-associated cholangitis.","volume":"24","author":"Bjornsson","year":"2008","journal-title":"Curr Opin Gastroenterol"},{"key":"R4-4-20210202","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/01.pas.0000136449.37936.6c","article-title":"IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: Do they belong to a spectrum of sclerosing pancreatitis?","volume":"28","author":"Zen","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R5-4-20210202","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.hepres.2004.03.006","article-title":"Analysis of 388 cases of primary sclerosing cholangitis in Japan: Presence of a subgroup without pancreatic involvement in older patients.","volume":"29","author":"Takikawa","year":"2004","journal-title":"Hepatol Res"},{"key":"R6-4-20210202","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1572-0241.2006.00772.x","article-title":"Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis.","volume":"101","author":"Mendes","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R7-4-20210202","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","article-title":"Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy.","volume":"134","author":"Ghazale","year":"2008","journal-title":"Gastroenterology"},{"key":"R8-4-20210202","first-page":"561","article-title":"Nephelometric measurements of human IgG subclasses and their reference ranges.","volume":"52","author":"Vlug","year":"1994","journal-title":"Ann Biol Clin (Paris)"},{"key":"R10-4-20210202","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1572-0241.2007.01776.x","article-title":"Prospective evaluation of advanced molecular markers and imaging techniques in patients with indeterminate bile duct strictures.","volume":"103","author":"Levy","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R11-4-20210202","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.","volume":"38","author":"Broome","year":"1996","journal-title":"Gut"},{"key":"R12-4-20210202","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11894-008-0031-x","article-title":"Update on the diagnosis and treatment of autoimmune pancreatitis.","volume":"10","author":"Ghazale","year":"2008","journal-title":"Curr Gastroenterol Rep"},{"key":"R13-4-20210202","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/j.1572-0241.2007.01264.x","article-title":"Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer.","volume":"102","author":"Ghazale","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R14-4-20210202","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1542-3565(03)00221-0","article-title":"Involvement of the biliary system in autoimmune pancreatitis: a follow-up study.","volume":"1","author":"Hirano","year":"2003","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R15-4-20210202","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1478-3231.1999.tb00083.x","article-title":"CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis.","volume":"19","author":"Bjornsson","year":"1999","journal-title":"Liver"},{"key":"R18-4-20210202","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1111\/j.1572-0241.2000.02323.x","article-title":"Oral budesonide in the treatment of primary sclerosing cholangitis.","volume":"95","author":"Angulo","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"R19-4-20210202","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2036.1994.tb00334.x","article-title":"Oral budesonide for treatment of autoimmune chronic active hepatitis.","volume":"8","author":"Danielsson A and Prytz","year":"1994","journal-title":"Aliment Pharmacol Ther"},{"key":"R20-4-20210202","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.510310209","article-title":"Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid.","volume":"31","author":"Angulo","year":"2000","journal-title":"Hepatology"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MJT.0b013e3181c9dac6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:35:28Z","timestamp":1620963328000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-201105000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e3181c9dac6","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}